bOPV: Clinical Trials

4 completed, 3 unknown. 5 Phase 4, 1 Not applicable, 1 Phase 3.

By phase and status

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Use of mOPV1 in Routine Immunization in Pakistan. mOPV, bOPV, Full dose IPV - Oral Polio Vaccine	Not applicable	Unknown	Aga Khan University	560	2020-08-01	2020-08-07
Monovalent Oral Poliovirus Vaccine Type 1 Intestinal and Humoral Immunity Study mOPV1, bOPV, fIPV - Poliomyelitis	Phase 4	Completed	Centers for Disease Control and Prevention	1256	2018-12-18	2021-02-21
Immunogenicity and Safety Profile of Primary Dose of bOPV Bio Farma Given Simultaneously With Pentabio And IPV bOPV, Pentabio, IPV - Healthy	Phase 4	Completed	PT Bio Farma	143	2016-07-01	2017-11-08
Assessment of Community Transmission of Sabin Type 2 Virus in Bangladesh tOPV, bOPV, IPV - Vaccine Virus Shedding	Phase 3	Unknown	University of Virginia	810	2015-04-01	2016-10-26
Polio End-game Strategies - Poliovirus Type 2 Challenge Study IPV, bOPV, bOPV and IPV - Poliomyelitis	Phase 4	Completed	Aga Khan University	900	2014-09-01	2016-05-03
Safety and Immunogenicity of 1 or 2 Doses of IPV in Latin American Infants Primed With Bivalent OPV Vaccine Bivalent Oral Polio Vaccine (bOPV), Trivalent Oral Polio Vaccine (tOPV), Monovalent Oral Polio Vaccine Type 2 (mOPV2) - Poliomyelitis	Phase 4	Completed	Fidec Corporation	1420	2013-05-01	2015-08-06
Immunogenicity of 1 or 2 Doses of bOPV in Chilean Infants Primed With IPV Vaccine IPV, bOPV, mOPV type 2 - Polio	Phase 4	Unknown	University of Chile	570	2013-04-01	2014-05-20

Bangladesh (2) · Pakistan (2) · Chile (1) · Colombia (1) · Dominican Republic (1) · Guatemala (1) · Indonesia (1) · Panama (1)